New heart valve device shows early promise in small study
NCT ID NCT06510855
First seen May 17, 2026 · Last updated Jun 23, 2026 · Updated 4 times
Summary
This early study is testing a new device called the DurAVR™ THV System, which is a replacement heart valve placed through a small tube in the leg (TAVI procedure). The study includes 40 people with severe aortic stenosis or a failed surgical valve. The main goal is to see if the device is safe and feasible, looking at rates of death or disabling stroke at 30 days.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rigshospitalet
Copenhagen, Capital Region of Denmark, 2100, Denmark
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
DurAVR™ THV System (a replacement heart valve implanted via a catheter)
What this could lead to
If this device works well, it could offer a new, less invasive option for people with severe aortic stenosis who need a valve replacement.
What could go wrong
This is a very early, small study (40 people) focused on safety and feasibility. The device may not work as well as existing valves, and there are risks like bleeding, stroke, or death.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.